Low B and T lymphocyte attenuator expression on CD4+ T cells in the early stage of sepsis is associated with the severity and mortality of septic patients: a prospective cohort study

Table 2 Independent factors predicting 28-day mortality in patients with sepsis, severe sepsis, and septic shock

Variable	B	SE	Wald	P value	Odds ratio	95 % CI for EXP (B)
Variable	B	SE	Wald	P value	Odds ratio	Lower limit	Lower limit
Percentage of BTLA⁺/CD4⁺ T cells	−0.141	0.062	5.145	0.023	0.869	0.769	0.981
MFI of BTLA on CD4⁺ T cells	−0.106	0.067	2.508	0.113	0.900	0.789	1.025
MEDS	0.180	0.033	29.358	<0.001	1.197	1.121	1.277
PCT	0.022	0.015	2.206	0.137	1.103	0.993	1.054
ALC	0.256	0.277	0.856	0.355	1.292	0.751	2.221
Constant	−2.155	0.756	8.120	0.004	0.116

BTLA B and T lymphocyte attenuator, MFI mean of fluorescence intensities, MEDS mortality in emergency department sepsis score, PCT procalcitonin, ALC absolute lymphocyte count

ISSN: 1364-8535